Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial
- Barbour, A. P., Walpole, E. T., Mai, G. T., Barnes, E. H., Watson, D. I., Ackland, S. P., Martin, J. M., Burge, M., Finch, R., Karapetis, C. S., Shannon, J., Nott, L. M., Varma, S., Marx, G., Falk, G. L., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G.
- Tremblay, Cedric S., Chiu, Sung Kai, Saw, Jesslyn, McCalmont, Hannah, Litalien, Veronique, Boyle, Jacqueline, Sonderegger, Stefan E., Chau, Ngoc, Evans, Kathryn, Cerruti, Loretta, Salmon, Jessica M., McCluskey, Adam, Lock, Richard B., Robinson, Phillip J., Jane, Stephen M., Curtis, David J.
Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer
Tumor-infiltrating lymphocytes and prognosis: a poled individual patient analysis of early-stage triple-negative breast cancers
- Loi, Sherene, Drubay, Damien, Gray, Robert, Munzone, Elisabetta, Lemonnier, Jerome, Sotiriou, Christos, Piccart, Martine, Kellokumpu-Lehtinen, Pirkko-Liisa, Vingiani, Andrea, Gray, Kathryn, Andre, Fabrice, Denkert, Carsten, Adams, Sylvia, Salgado, Roberto, Michiels, Stefan, Pruneri, Giancarlo, Francis, Prudence, Lacroix-Triki, Magali, Joensuu, Heikki, Dieci, Maria Vittoria, Badve, Sunil, Demaria, Sandra
A mobile application of a breast cancer e-support program for Chinese women with breast cancer undergoing chemotherapy
Genomic integrity in the male germ line: evidence in support of the disposable soma hypothesis
Mobile breast cancer e-support program for Chinese women with breast cancer undergoing chemotherapy (Part 1): qualitative study of women's perceptions
Mobile breast cancer e-support program for Chinese women with breast cancer undergoing chemotherapy (Part 2): multicenter randomized controlled trial
Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era
p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial
- Sonnenblick, Amir, Salgado, Roberto, Crown, John, Viale, Giuseppe, Daly, Laura, Javdan, Bahar, Fujisawa, Sho, de Azambuja, Evandro, Lieveke, Ameye, Piccart, Martine, Bromberg, Jacqueline, Sotirou, Christos, Brohee, Sylvain, Zahavi, Tamar, Peretz, Tamar, van den Eynden, Gert, Rouas, Ghizlaine, Salmon, Asher, Francis, Prudence A., Di Leo, Angelo
The timeliness of patients reporting the side effects of chemotherapy.
A decision aid for women considering neoadjuvant systemic therapy for operable invasive breast cancer: development and protocol of a phase II evaluation study (ANZ1301 DOMINO)
A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer
A systematic review of decision aids for patients making a decision about treatment for early breast cancer
Enhancement of oncolytic coxasckievirus A21 with conventional chemotherapies and immune checkpoint inhibitors for the treatment of melanoma
Are you sure you would like to clear your session, including search history and login status?